The Fosun-backed eye disease treatment developer has filed for a $100m initial public offering, having raised over $250m in funding in the past two years.

Synthesia was co-founded by researchers at UCL, Stanford, Cambridge and TUM to build a platform that generates video content using artificial intelligence.

Lumicks, which is developing single-molecule analysis technology based on research at Vrije Universiteit Amsterdam, has collected $93m.

SoftBank’s Vision Fund 2 has taken part in a series D round for Lumicks, which is developing single-molecule analysis technology.

University of Sheffield spinout Rinri Therapeutics has collected $13.9m from investors including Boehringer Ingelheim Venture Fund and UCB Ventures.

EV Growth-backed online education platform developer Ruangguru pulled in $55m while ProSieben and Rocket Internet helped open banking platform developer Tink take its total funding to $344m.

Mercuria has invested in rare metal provider TechMet, which has now secured $170m in total and which is already planning to raise a further $250m.

Alchemab Therapeutics has raised $80m to advance research originating at University of Oxford, Johns Hopkins University and Mount Sinai Hospital.

E-commerce platform developer Olist added $23m to a SoftBank-backed round now topping $80m, while Waters Corporation-backed TetraScience closed its series B at $80m.

SK Group was among the participants in a round representing the first external funding for Volvo Cars' electric vehicle spinoff.